Amryt Pharma is pleased to announce that the High Court of Justice of England and Wales has sanctioned the scheme of arrangement providing for the proposed acquisition of Amryt by Chiesi Farmaceutici at a hearing held on March 31, 2023. The parties expect the closing of the Transaction to take place in mid-April 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AMYT:
- Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
- Amryt Pharma shareholders approve acquisition by Chiesi Farmaceutici
- Amryt Pharma publishes scheme circular, announces shareholder meetings
- AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023